# Traffic and functional polarization of macrophages in the areas of programmed interdigital cell death in the embryonic chick

**Authors:** G. Moran, C. Duarte-Olivenza, J. M. Hurle, C. I. Lorda-Diez, J. A. Montero

PMC · DOI: 10.1007/s10495-026-02303-4 · Apoptosis · 2026-03-07

## TL;DR

The study explores how macrophages contribute to digit development in embryonic chicks through distinct populations and functional roles during tissue remodeling.

## Contribution

The paper identifies two distinct macrophage populations with different origins and molecular profiles during embryonic digit development.

## Key findings

- Resident macrophages precede interdigital cell death in embryonic limb development.
- Macrophages exhibit an M2/anti-inflammatory gene signature during tissue remodeling.
- M1-proinflammatory genes are upregulated at the end of tissue remodeling.

## Abstract

In this study, we show that during digit development, the embryonic limb contains an abundant and widespread population of “resident macrophages” that precede the onset of interdigital cell death responsible for the separation of digit primordia. The use of cultures of interdigital mesoderm at different remodeling stages, and GFP+ transgenic embryos in which the distal part of the autopodium has been surgically replaced by a fragment with identical characteristics from wild-type embryos, indicate that “transient macrophages” are also recruited at the beginning of interdigital death. The expression of the Pu.1 gene in coincidence with the onset of interdigital death suggests that primary yolk-sac macrophages are later complemented by macrophages of hematopoietic origin. Q-PCR analysis revealed a predominant M2/anti-inflammatory gene signature in the interdigits during the whole remodeling process that correlated with an interdigital transcriptome including Csf1, Il-34, Igf1, Igfbp5, Tgfβ4 (Tgfβ1 in mammals), P75NTR/ Tnfrsf16, Hgf, Vegfa, that presumably stabilizes the macrophage M2 phenotype. However, M1-proinflammatory genes, including Tnfα and Tlr4, are expressed at very low levels prior to the onset of cell death but become up-regulated at the end of tissue remodeling. Together, our findings support the existence of “Tissue-Resident” and “Passenger/Transitory” macrophage populations of distinct origin and molecular profile participating in tissue remodeling processes associated with embryonic morphogenesis.

The online version contains supplementary material available at 10.1007/s10495-026-02303-4.

## Linked entities

- **Genes:** SPI1 (Spi-1 proto-oncogene) [NCBI Gene 6688], CSF1 (colony stimulating factor 1) [NCBI Gene 1435], IL34 (interleukin 34) [NCBI Gene 146433], IGF1 (insulin like growth factor 1) [NCBI Gene 3479], IGFBP5 (insulin like growth factor binding protein 5) [NCBI Gene 3488], LEFTY2 (left-right determination factor 2) [NCBI Gene 7044], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], NGFR (nerve growth factor receptor) [NCBI Gene 4804], NGFR (nerve growth factor receptor) [NCBI Gene 4804], HGF (hepatocyte growth factor) [NCBI Gene 3082], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], TNF (tumor necrosis factor) [NCBI Gene 7124], TLR4 (toll like receptor 4) [NCBI Gene 7099]
- **Species:** Gallus gallus (taxon 9031)

## Full-text entities

- **Genes:** FOXO1 (forkhead box O1) [NCBI Gene 374231] {aka FOXO1A}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, IL34 (interleukin 34) [NCBI Gene 100858424] {aka IL-34, Interleukin-34, chIL-34}, TAP1 (transporter 1, ATP binding cassette subfamily B member, MHCB region) [NCBI Gene 427727], IL1B (interleukin 1, beta) [NCBI Gene 395196] {aka IL-1BETA, IL1beta}, CSF1R (colony stimulating factor 1 receptor) [NCBI Gene 396406] {aka CSF-1R}, HGF (hepatocyte growth factor) [NCBI Gene 395941] {aka HGF/SF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, GLB1 (galactosidase beta 1) [NCBI Gene 420720], RUNX1 (runt-related transcription factor 1) [NCBI Gene 396152], IL4 (interleukin 4) [NCBI Gene 416330] {aka IL-4, Interleukin-4}, NOS2 (nitric oxide synthase 2) [NCBI Gene 395807] {aka INOS, NOS2A}, RPL13 (ribosomal protein L13) [NCBI Gene 395849] {aka BBC1}, STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 100859196], IFNW1 (interferon omega 1) [NCBI Gene 554219] {aka IFN-beta, IFN2, IFNB, IFN_B}, IL6 (interleukin 6) [NCBI Gene 395337] {aka CHIL-6, IL-6, interleukin-6}, ITGAD (integrin, alpha D) [NCBI Gene 101748640] {aka cd11b}, Acsm3 (acyl-CoA synthetase medium-chain family member 3) [NCBI Gene 20216] {aka Sa, Sah}, IL16 (interleukin 16) [NCBI Gene 374270] {aka interleukin-16}, Tap1 (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) [NCBI Gene 21354] {aka ABC17, APT1, Abcb2, Ham-1, Ham1, MTP1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 395909] {aka VEGF}, Csf1r (colony stimulating factor 1 receptor) [NCBI Gene 12978] {aka CD115, CSF-1R, Csfmr, Fim-2, Fim2, Fms}, IL10 (interleukin 10) [NCBI Gene 428264] {aka IL-10, interleukin-10}, IGFBP5 (insulin like growth factor binding protein 5) [NCBI Gene 424220], SPI1 (Spi-1 proto-oncogene) [NCBI Gene 6688] {aka AGM10, OF, PU.1, SFPI1, SPI-1, SPI-A}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 424044], INFG (interferon gamma) [NCBI Gene 396054] {aka IFNG}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, SPI1 (Spi-1 proto-oncogene) [NCBI Gene 395879], Spi1 (Spi-1 proto-oncogene) [NCBI Gene 20375] {aka Dis-1, Dis1, PU.1, Sfpi-1, Sfpi1, Spi-1}, CCR2 (C-C motif chemokine receptor 2) [NCBI Gene 420696] {aka CCR5-L}, IL13 (interleukin 13) [NCBI Gene 474361], MYB (MYB proto-oncogene, transcription factor) [NCBI Gene 396244] {aka c-myb}, LITAF (lipopolysaccharide induced TNF factor) [NCBI Gene 374125] {aka TNF-alpha}, TLR4 (toll like receptor 4) [NCBI Gene 417241], PPARG (peroxisome proliferator-activated receptor gamma) [NCBI Gene 373928] {aka PPARgamma, PPARgamma2}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 100873157] {aka TGF-beta4, TGFB4}, CEBPB (CCAAT/enhancer binding protein beta) [NCBI Gene 396185] {aka NF-M}, CSF1 (colony stimulating factor 1) [NCBI Gene 1435] {aka CSF-1, MCSF, PG-M-CSF}, IL34 (interleukin 34) [NCBI Gene 146433] {aka C16orf77, IL-34}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, CSF1R (colony stimulating factor 1 receptor) [NCBI Gene 1436] {aka BANDDOS, C-FMS, CD115, CSF-1R, CSFR, FIM2}, IGF1 (insulin like growth factor 1) [NCBI Gene 418090] {aka IGF-1, IGF-I}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 420027], CSF1 (colony stimulating factor 1) [NCBI Gene 100499189] {aka CSF-1}, IL4R (interleukin 4 receptor) [NCBI Gene 416585] {aka IL4RA}, Timd4 (T cell immunoglobulin and mucin domain containing 4) [NCBI Gene 276891] {aka B430010N18Rik, TIM-4, Tim4}, IRF4 (interferon regulatory factor 4) [NCBI Gene 374179], KLF4 (Kruppel like factor 4) [NCBI Gene 770254], CX3CR1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 1524] {aka CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28}, NOTCH1 (notch 1) [NCBI Gene 395655]
- **Diseases:** inflammatory (MESH:D007249), cancer (MESH:D009369), metastasis (MESH:D009362), CDO (MESH:C536444), necrotic (MESH:D009336)
- **Chemicals:** paraffin (MESH:D010232), CDO (MESH:C029663), NR (MESH:D009499), Toluidine-blue (MESH:D014048), BCIP (-), SA (MESH:D000077145), digoxigenin (MESH:D004076), Hematoxylin (MESH:D006416), L-glutamine (MESH:D005973), rhodamine-phalloidin (MESH:C504731), PBS (MESH:D007854), glutaraldehyde (MESH:D005976), eosin (MESH:D004801), DAPI (MESH:C007293)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Gallus gallus (bantam, species) [taxon 9031]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967454/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967454/full.md

---
Source: https://tomesphere.com/paper/PMC12967454